Generation of HEK-293 stable cell lines with disrupted expression of ribosomal protein S6 kinase (S6K1) isoforms using the CRISPR/Cas9 genome editing system
Aim. To generate HEK-293 cells with disrupted expression of S6K1 isoforms: p85, p70 and p60. Methods. CRISPR/Cas9 gene editing, Western blotting, immunofluorescent analysis, RT-PCR analysis, MTT assay, scratch assay. Results. Several clones of HEK-293 cells with a complete loss of p85/p70/p60-S6K1 p...
Saved in:
| Published in: | Вiopolymers and Cell |
|---|---|
| Date: | 2017 |
| Main Authors: | Zaiets, I.V., Sivchenko, A.S., Khoruzhenko, A.I., Filonenko, V.V. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут молекулярної біології і генетики НАН України
2017
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/152987 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Generation of HEK-293 stable cell lines with disrupted expression of ribosomal protein S6 kinase (S6K1) isoforms using the CRISPR/Cas9 genome editing system / I.V. Zaiets, A.S. Sivchenko, A.I. Khoruzhenko, V.V. Filonenko // Вiopolymers and Cell. — 2017. — Т. 33, № 5. — С. 356-366. — Бібліогр.: 39 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Generation and characterization of polyclonal antibodies specific to N-terminal extension of p85 isoform of ribosomal protein S6 kinase 1 (p85 S6K1)
by: Savinska, L.O., et al.
Published: (2015)
by: Savinska, L.O., et al.
Published: (2015)
The r60-S6K1 isoform of ribosomal protein S6 kinase 1 is a product of alternative mRNA translation
by: I. V. Zaiets, et al.
Published: (2018)
by: I. V. Zaiets, et al.
Published: (2018)
CRISPR/Cas9 technology for targeted genome editing
by: N. A. Lomov, et al.
Published: (2015)
by: N. A. Lomov, et al.
Published: (2015)
CRISPR/Cas9 technology for targeted genome editing
by: Lomov, N.A., et al.
Published: (2015)
by: Lomov, N.A., et al.
Published: (2015)
p60-S6K1 represents a novel kinase active isoform with the mode of regulation distinct from p70/p85-S6K1 isoforms
by: I. V. Zaiets, et al.
Published: (2019)
by: I. V. Zaiets, et al.
Published: (2019)
Subcellular localization of S6K1 and S6K2 forms of ribosomal protein S6 kinase in primary monolayer culture of rat thyrocytes
by: Khoruzhenko, A.I., et al.
Published: (2008)
by: Khoruzhenko, A.I., et al.
Published: (2008)
Generation and characterization of polyclonal antibodies specific to N-terminal extension of p85 isoform of ribosomal protein S6 kinase 1 (p85 S6K1)
by: L. O. Savinska, et al.
Published: (2015)
by: L. O. Savinska, et al.
Published: (2015)
Adaptor protein TDRD7 is co-localized with ribosomal protein S6 kinases S6K1 and S6K2 in cell lines of different tissue origin
by: O. M. Skorokhod, et al.
Published: (2013)
by: O. M. Skorokhod, et al.
Published: (2013)
Adaptor protein TDRD7 is co-localized with ribosomal protein S6 kinases S6K1 and S6K2 in cell lines of different tissue origin
by: Skorokhod, O.M., et al.
Published: (2013)
by: Skorokhod, O.M., et al.
Published: (2013)
Generation of monoclonal antibodies specific to ribosomal protein S6 kinase 1
by: L. O. Savinska, et al.
Published: (2012)
by: L. O. Savinska, et al.
Published: (2012)
Generation of monoclonal antibodies specific to ribosomal protein S6 kinase 1
by: Savinska, L.O., et al.
Published: (2012)
by: Savinska, L.O., et al.
Published: (2012)
Genome editing, or CRISPR/CAS9 — a panacea for many incurable diseases or the first step to a gene apocalypse?
by: S. V. Komisarenko, et al.
Published: (2020)
by: S. V. Komisarenko, et al.
Published: (2020)
Identification of Tudor domain containing 7 protein as a novel partner and a substrate for ribosomal protein S6 kinases – S6K1 and S6K2
by: O. Skorokhod, et al.
Published: (2013)
by: O. Skorokhod, et al.
Published: (2013)
Identification of a novel S6K1 splice variant coding for the p60-S6K1 isoform
by: Zaiets, I.V., et al.
Published: (2019)
by: Zaiets, I.V., et al.
Published: (2019)
Consistent production of mice with conditional knockout alleles by CRISPR/Cas9-mediated genome editing using two guides/two oligos approach
by: A. Golovko, et al.
Published: (2020)
by: A. Golovko, et al.
Published: (2020)
Colocalization of cortactin and PH domain of BCR in HEK293T cells and its potential role in cell signaling.
by: D. S. Gurianov, et al.
Published: (2016)
by: D. S. Gurianov, et al.
Published: (2016)
Colocalization of cortactin and PH domain of BCR in HEK293T cells and its potential role in cell signaling
by: Gurianov, D.S., et al.
Published: (2016)
by: Gurianov, D.S., et al.
Published: (2016)
Crambe aspera plants in vitro propagation and its effect on fatty acids and phenolic compounds content and genome stability
by: Pushkarova, N.O., et al.
Published: (2019)
by: Pushkarova, N.O., et al.
Published: (2019)
Зміни в експресії генів, зумовлені надекспресією транскрипційного фактора ZXDC в ембріональних клітинах нирки лінії HEK293
by: Галкін, О.В., et al.
Published: (2010)
by: Галкін, О.В., et al.
Published: (2010)
Редагування геному, або CRISPR/CAS9 — панацея від багатьох невиліковних хвороб чи перший крок до генного апокаліпсису?
by: Комісаренко, С.В., et al.
Published: (2020)
by: Комісаренко, С.В., et al.
Published: (2020)
Prospects for gene editing using CRISPR/Cas, or how to master the "genetic scissors" (Nobel Prize in Chemistry for 2020)
by: S. V. Komisarenko, et al.
Published: (2020)
by: S. V. Komisarenko, et al.
Published: (2020)
Перспективи редагування геному за допомогою CRISPR/Cas, або як опанувати "генетичні ножиці" (Нобелівська премія з хімії 2020 року)
by: Комісаренко, С.В., et al.
Published: (2020)
by: Комісаренко, С.В., et al.
Published: (2020)
Dominant-negative constructs of human 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 and -4: effect on the expression of endogenous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA
by: Minchenko, D.O., et al.
Published: (2008)
by: Minchenko, D.O., et al.
Published: (2008)
Enhanced biomass, lipid and bioactive compounds from CRISPR-Cas9, CRISPRi and ASGARD based genetically modified microalgae: a promising frontier in biotechnology
by: Josephine, A., et al.
Published: (2025)
by: Josephine, A., et al.
Published: (2025)
Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular signal-regulated kinases ERK1/ERK2 in human embryonic kidney (hek293) and human glioblastoma (U87 MG) cells
by: Areshkov, P.A., et al.
Published: (2010)
by: Areshkov, P.A., et al.
Published: (2010)
Characterization of novel peptide-specific antibodies against the translation elongation factor eEF1A2 and their application for cancer research
by: Shalak, V.F., et al.
Published: (2014)
by: Shalak, V.F., et al.
Published: (2014)
Хітиназо-3-подібний білок 2 (CHI3l2) активує сигнальний каскад ERK1/2 у клітинах ембріональної нирки людини (HEK293)
by: Арешков, П.О., et al.
Published: (2009)
by: Арешков, П.О., et al.
Published: (2009)
Identification of novel TDRD7 isoforms
by: Skorokhod, O.M., et al.
Published: (2011)
by: Skorokhod, O.M., et al.
Published: (2011)
Creation of a genetic vector carrying a synthesis bacterial protein gene CAS9 for plant genome editing
by: I. S. Hnatiuk, et al.
Published: (2020)
by: I. S. Hnatiuk, et al.
Published: (2020)
Effect of silver nanoparticles on the expression of circadian genes and 6- phosphofructo-2-kinase/fructose-2,6- bisphosphatase-4 in rat brain
by: D. O. Minchenko, et al.
Published: (2010)
by: D. O. Minchenko, et al.
Published: (2010)
P60-S6K1 mRNA transcript expression profile in a panel of cell lines and breast cancer tissue samples
by: V. V. Holiar, et al.
Published: (2018)
by: V. V. Holiar, et al.
Published: (2018)
Mouse embryonic fibroblasts expressing IFNβ or IL-21 inhibit proliferation of melanoma cells in vitro
by: Vagyna, I.N., et al.
Published: (2016)
by: Vagyna, I.N., et al.
Published: (2016)
Biological properties of neural crest-derived multipotent stem cells from the bulge region of whisker follicle expanded in new culture conditions
by: Vasyliev, R.G., et al.
Published: (2014)
by: Vasyliev, R.G., et al.
Published: (2014)
SPR investigations of the formation of intermediate layer of the immunosensor bioselective element based on the recombinant Staphylococcal protein A
by: Rachkov, A.E., et al.
Published: (2015)
by: Rachkov, A.E., et al.
Published: (2015)
Expression and secretion of human recombinant LIF by genetically modified mammalian cells
by: Rymar, S.Yu., et al.
Published: (2011)
by: Rymar, S.Yu., et al.
Published: (2011)
Development of the chromatographic medium for the affinity isolation of the recombinant hIFN-β1b based on immobilized single-chain antibodies
by: Pokholenko, Ia.O., et al.
Published: (2015)
by: Pokholenko, Ia.O., et al.
Published: (2015)
Antioxidant capacity and sustainability of Saccharomyces cerevisiae cells exposed to ozone
by: Goriacha, I.P., et al.
Published: (2014)
by: Goriacha, I.P., et al.
Published: (2014)
Potentiality of application of the conductometric L-arginine biosensors for the real sample analysis
by: Saiapina, O.Y., et al.
Published: (2012)
by: Saiapina, O.Y., et al.
Published: (2012)
Characterization of vaccine and field IBDV strains in Ukraine for proper vaccine selection for disease prevention
by: Pastyria, A.S., et al.
Published: (2018)
by: Pastyria, A.S., et al.
Published: (2018)
Highly selective amperometric biosensor for uric acid determination in real samples
by: Zinchenko, O.A., et al.
Published: (2017)
by: Zinchenko, O.A., et al.
Published: (2017)
Similar Items
-
Generation and characterization of polyclonal antibodies specific to N-terminal extension of p85 isoform of ribosomal protein S6 kinase 1 (p85 S6K1)
by: Savinska, L.O., et al.
Published: (2015) -
The r60-S6K1 isoform of ribosomal protein S6 kinase 1 is a product of alternative mRNA translation
by: I. V. Zaiets, et al.
Published: (2018) -
CRISPR/Cas9 technology for targeted genome editing
by: N. A. Lomov, et al.
Published: (2015) -
CRISPR/Cas9 technology for targeted genome editing
by: Lomov, N.A., et al.
Published: (2015) -
p60-S6K1 represents a novel kinase active isoform with the mode of regulation distinct from p70/p85-S6K1 isoforms
by: I. V. Zaiets, et al.
Published: (2019)